The obesity paradox of mortality in patients with coronary artery disease undergoing percutaneous coronary intervention

被引：3
|
作者：
Lin, Gen-Min [1 ]
Li, Yi-Hwei [2 ]
Jaiteh, Lamin E. S. [3 ]
Han, Chih-Lu [4 ]
机构：
[1] Hualien Armed Forces Gen Hosp, Dept Med, Hualien 97144, Hualien County, Taiwan
[2] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan
[3] Royal Victoria Teaching Hosp, Dept Med, Banjul, Gambia
[4] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 02期
关键词：
The obesity paradox; Coronary artery disease; Percutaneous coronary intervention;
D O I：
10.1016/j.ijcard.2012.09.216
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [31] Obesity paradox in patients with hypertension and coronary artery disease
    Uretsky, Seth
    Messerli, Franz H.
    Bangalore, Sripal
    Champion, Annette
    Cooper-DeHoff, Rhonda M.
    Zhou, Qian
    Pepine, Carl J.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2007, 120 (10): : 863 - 870
  • [32] Determinants of Mortality in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
    Papachristidis, Alexandros
    Lim, Wei Yao
    Voukalis, Christos
    Ayis, Salma
    Laing, Christopher
    Rakhit, Roby D.
    [J]. CARDIORENAL MEDICINE, 2016, 6 (03) : 169 - 179
  • [33] Predictors of mortality in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Constantinides, SS
    Gieowarsingh, S
    Halim, M
    Been, M
    Shiu, MF
    [J]. HEART, 2003, 89 (10) : 1245 - 1246
  • [34] Obesity paradox in coronary artery disease
    Akin, Ibrahim
    Nienaber, Christoph A.
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2015, 7 (10): : 603 - 608
  • [35] Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Li, Jianan
    Qiu, Hong
    Yan, Lirong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Tang, Yida
    Xu, Bo
    Qiao, Shubin
    Yang, Yuejin
    Gao, Runlin
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (08) : 873 - 882
  • [36] Prognostic implication of progression of diastolic dysfunction in patients with coronary artery disease undergoing percutaneous coronary intervention
    Hahn, Joo-Yong
    Song, Young Bin
    Gwon, Hyeon-Cheol
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B289 - B289
  • [37] The impact of unfractionated heparin or bivalirudin on patients with stable coronary artery disease undergoing percutaneous coronary intervention
    Lima, Fabio V.
    Gruberg, Luis
    Aslam, Usman
    Ramgadoo, Melissa
    Clase, Kydanis
    Trevisan, Alessandra
    Jeremias, Allen
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (02) : 177 - 184
  • [38] Prognostic Implications of Diastolic Dysfunction Change in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Kim, Eun Kyoung
    Hahn, Joo-Yong
    Park, Taek Kyu
    Lee, Joo Myung
    Bin Song, Young
    Chang, Sung-A
    Park, Sung-Ji
    Choi, Seung-Hyuk
    Lee, Sang-Chol
    Gwon, Hyeon-Cheol
    Oh, Jae K.
    Park, Seung Woo
    [J]. CIRCULATION JOURNAL, 2019, 83 (09) : 1891 - +
  • [39] Prognostic implication of progression of diastolic dysfunction in patients with coronary artery disease undergoing percutaneous coronary intervention
    Kim, E. K.
    Hahn, Y. J.
    Song, Y. B.
    Choi, S. H.
    Gwon, H. C.
    Park, S. J.
    Lee, S. C.
    Park, S. W.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 813 - 814
  • [40] Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention
    Zhao, Xin
    Ma, Sicong
    Kang, Yi
    Tang, Chengchun
    Liu, Bin
    Jiang, Hong
    Zheng, Mingqi
    Tang, Yu
    Sun, Hongbin
    Liu, Yongqiang
    Lai, Xiaojuan
    Gong, Yanchun
    Li, Yongguo
    Qi, Zizhao
    Ren, Ling
    Li, Jing
    Li, Yi
    Han, Yaling
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (08) : 806 - 814
12345